Semaglutide 7 mg and weight loss: what this dose actually means

You've seen "7 mg semaglutide", here's the situation you're probably in

You may have come across a 7 mg figure in a forum, on a comparison site, or on a box belonging to someone with diabetes. It's easy to see why it creates confusion: semaglutide is semaglutide, and if one product works for blood sugar, surely another dose of the same drug works for weight? The reality is more specific than that.

Rybelsus is oral semaglutide, but it was developed and licensed for a different job. Its three strengths (3 mg (a starter), 7 mg (mid-range), and 14 mg (maintenance)) are calibrated for glycaemic control in people with type 2 diabetes. The MHRA has not licensed Rybelsus for weight management, and it would be outside clinical guidelines to prescribe it for that purpose. You can read more about how semaglutide's dose schedule is structured for weight loss specifically on our semaglutide dosage chart, which maps the Wegovy pathway clearly.

If you have type 2 diabetes and weight management is part of your treatment conversation, that's exactly the kind of nuanced clinical situation a prescriber needs to walk through with you. A 7 mg Rybelsus tablet might be entirely appropriate in your care, but it would be prescribed by a clinician treating your diabetes, not sourced as a weight-loss product through a private pharmacy.

Worth knowing: using a medicine outside its licensed indication carries real clinical risk, and it also puts you outside the safety net of a properly supervised programme.

What the licensed semaglutide weight-loss doses actually look like

For weight management, semaglutide is available in two forms in the UK: the Wegovy weekly injection and, since June 2026, the Wegovy tablet.

The injection follows a gradual upward titration. Treatment opens at a very low dose (0.25 mg weekly) which is there primarily to let your body adjust before moving to doses that do the heavier therapeutic work. Each step up happens roughly every four weeks, guided by the prescriber. The standard maintenance dose has been 2.4 mg, and the MHRA approved a higher 7.2 mg dose in early 2026 for adults with a BMI of 30 or above. That 7.2 mg figure is often what people are actually searching for when they type "7 mg semaglutide", it's close enough to cause genuine confusion. Our Wegovy doses page covers the full injection schedule, including the newer 7.2 mg option.

The Wegovy tablet works differently. It uses a special formulation to get semaglutide absorbed through the gut wall, something the standard molecule struggles with. Its dose steps are 1.5 mg, 4 mg, 9 mg, and 25 mg, none of which overlap with Rybelsus. The loading dose for the tablet is 1.5 mg daily, taken first thing in the morning on an empty stomach, with a small amount of plain water, waiting at least 30 minutes before food, coffee or other medicines.

Clinical trial data for Wegovy's injection has shown around 15% average weight reduction over 68 weeks at the 2.4 mg dose, as reported in the STEP 1 trial published in the New England Journal of Medicine. The oral form, studied in the OASIS 4 trial, showed roughly 13.6% average weight loss over 64 weeks, rising to around 17% among participants who stayed fully adherent. These figures are averages from controlled trials; individual results depend on many factors including diet, activity and starting weight.

Why the 7 mg confusion matters for your safety

A search for "semaglutide 7 mg" occasionally surfaces sellers (particularly on social media or through unofficial channels) offering medicines without a proper prescription process. Some of those listings are counterfeit. The MHRA has warned repeatedly about fake weight-loss pens circulating online, and enforcement in 2025 led to the seizure of around 20 million doses of illegally traded weight-loss medicines worth approximately £45 million. Fake pens have in some cases contained insulin rather than semaglutide, with serious consequences for people who injected them.

The safe route to any semaglutide product is a prescription issued after a proper clinical assessment. You can verify any online pharmacy on the GPhC register; a registered pharmacy will be listed there. Sellers who supply prescription medicines without that process are operating outside UK law, regardless of how their listings are worded. If you want to understand the broader semaglutide dosing landscape before booking a consultation, that page covers the clinical logic behind how doses are chosen and stepped up.

Suspect anything that looks too cheap or that arrives without a consultation. Report concerns to the MHRA via the Yellow Card scheme, which also accepts reports about suspected counterfeit or unlicensed medicines.

If you're considering semaglutide for weight loss, where to start

The right starting point is understanding whether Wegovy (injection or tablet) is clinically suitable for you. The licensed eligibility threshold is a BMI of 30 or above, or 27 to 29.9 alongside at least one weight-related health condition such as high blood pressure, type 2 diabetes, or raised cholesterol. Lower BMI thresholds apply for some ethnic backgrounds under UK guidance. BMI alone doesn't settle the question; contraindications, current medicines, and your wider health history all feed into it.

There is a separate question of which formulation suits you. Some people strongly prefer not to inject; others find weekly injections straightforward. The tablet's morning routine (empty stomach, plain water, 30-minute wait before anything else) suits some lifestyles better than others. Our Wegovy overview sets out both options side by side, and the 2.4 mg maintenance dose page goes deeper on what the injection's endpoint looks like clinically.

If you're already on treatment and have questions about a specific dose step, our FAQs cover common titration queries, and the contact page connects you with our support team, available seven days a week. For a full look at the weight-management options nume offers, the weight loss overview is a sensible next step before booking anything.

When you're ready to talk to a prescriber, a free consultation through our treatment page is the place to start. A real clinician reads your answers the same day, your case lands on a prescriber's desk, not in a queue for an algorithm.